Article of the Month – April 2022
April 1, 2022
AI double-checks ventilator tube placemen, Injectable Cardiac Monitor Can Now Look for Signs of Fever, FDA clears Zebra Medical Vision…
May 1, 2022United States of America
AI Leadership Initiative
Artificial intelligence (AI) has been described as a game-changer, as it grants enormous power to countries and companies that utilize its full potential. As a long-standing leader in the modern era, the United States of America has consistently developed and implemented strategies to guarantee its superiority in the rapidly growing field of AI.(1)
In 2020, the Federal Government launched the National AI Initiative to secure enough resources for proper AI innovation. AI innovation can enhance economic prosperity, increase national security, and improve quality of life. Among its key policies, the initiative encourages a thorough collaboration between industries, academic centers, and international allies to generate groundbreaking technological advances.
The initiative also aims to prepare current and future generations of American workers for integrating AI systems across all sectors of the economy and society.(2,3)To ensure a well-regulated AI development, the Federal Government has also mandated a series of governing principles to uphold the privacy, civil rights, and civil liberties. These guidelines aim to support three main goals: ensuring public engagement, limiting regulatory overreach, and promoting trustworthy AI products/services.(2,4)
Artificial intelligence (AI) has been described as a game-changer, as it grants enormous power to countries and companies that utilize its full potential. As a long-standing leader in the modern era, the United States of America has consistently developed and implemented strategies to guarantee its superiority in the rapidly growing field of AI.(1)
In 2020, the Federal Government launched the National AI Initiative to secure enough resources for proper AI innovation. AI innovation can enhance economic prosperity, increase national security, and improve quality of life. Among its key policies, the initiative encourages a thorough collaboration between industries, academic centers, and international allies to generate groundbreaking technological advances.
The initiative also aims to prepare current and future generations of American workers for integrating AI systems across all sectors of the economy and society.(2,3)To ensure a well-regulated AI development, the Federal Government has also mandated a series of governing principles to uphold the privacy, civil rights, and civil liberties. These guidelines aim to support three main goals: ensuring public engagement, limiting regulatory overreach, and promoting trustworthy AI products/services.(2,4)
The National AI Initiative provides an overarching framework to coordinate AI research and development in every national domain, including healthcare. For example, the U.S. Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) have partnered to advance machine learning and natural language processing by creating tools to improve clinical data collection through AI medical software. This type of collaborative work between a broad spectrum of Federal Agencies and the private sector has proven essential for the U.S. to keep its dominant position in the modern technological era.(5)
The National AI Initiative provides an overarching framework to coordinate AI research and development in every national domain, including healthcare. For example, the U.S. Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) have partnered to advance machine learning and natural language processing by creating tools to improve clinical data collection through AI medical software.
This type of collaborative work between a broad spectrum of Federal Agencies and the private sector has proven essential for the U.S. to keep its dominant position in the modern technological era.(5)
Freenome
Freenome is a biotech company founded in 2014. It has pioneered the most comprehensive multi-omics platform for early-stage cancer detection by running its algorithms on thousands of disease-positive samples. The organization incorporates molecular biology information, revolutionary analytical biology, and expert system procedures to determine illness-associated patterns among billions of circulating cell-free biomarkers. With a simple blood draw test, its platform can detect cancer. It also enhances an intelligent retrieval feedback loop with healthcare providers to credit real-world data and augment patient care through prompt detection.(6)
In 2022, Freenome announced the initiation of a clinical study to develop its multi-omics platform further to detect multiple cancers. Recent data has shown a strong performance in detecting early-stage colorectal cancer with a sensitivity of 94% and a specificity of 94%. With a nearly $300 million budget, this company is on the verge of a new early cancer detection era.(7,8)
In 2022, Freenome announced the initiation of a clinical study to develop its multi-omics platform further to detect multiple cancers. Recent data has shown a strong performance in detecting early-stage colorectal cancer with a sensitivity of 94% and a specificity of 94%. With a nearly $300 million budget, this company is on the verge of a new early cancer detection era.(7,8)
Enlitic
Enlitic is a pioneer in developing healthcare solutions by creating AI-powered workflow platforms. Since its foundation in 2014, this company has consistently tackled inefficiencies in the healthcare environment. In 2022, it is expected that the company will reveal its latest product Curie™, a completely standardized platform to provide AI-powered solutions for reading and reporting healthcare data.(9,10)
The company recently announced its unique algorithms will be integrated directly into a national cloud infrastructure. This cloud support will include enterprise-level Hospital Information System (“HIS”) and Picture Archiving and Communications System (“PACS”) software that will conduct clinical studies to evaluate the impact of technologies on diagnostic quality and efficiency. The Massachusetts Institute of Technology named Enlitic the 5th most innovative AI company globally, ranking above Facebook and Microsoft.(9)
Enlitic is a pioneer in developing healthcare solutions by creating AI-powered workflow platforms. Since its foundation in 2014, this company has consistently tackled inefficiencies in the healthcare environment. In 2022, it is expected that the company will reveal its latest product Curie™, a completely standardized platform to provide AI-powered solutions for reading and reporting healthcare data.(9,10)
The company recently announced its unique algorithms will be integrated directly into a national cloud infrastructure. This cloud support will include enterprise-level Hospital Information System (“HIS”) and Picture Archiving and Communications System (“PACS”) software that will conduct clinical studies to evaluate the impact of technologies on diagnostic quality and efficiency. The Massachusetts Institute of Technology named Enlitic the 5th most innovative AI company globally, ranking above Facebook and Microsoft.(9)
Intuitive
Intuitive has been one of the pioneers of robotic-assisted surgery since 1995. This technology company is currently improving minimally invasive products such as the da Vinci surgical system. They envision a future with intelligent hospitals that would improve outcomes, lower the total cost of care, and improve patient experiences.(11)
One of its most ambitious projects is the Ion experience, an innovative robotic-assisted platform to enable minimally invasive biopsies that could become a crucial part of the early diagnosis of lung cancer. It is based on PlanPoint’s software that translates a CT scan of the patient’s lung into a 3D model map to determine the nodules that need a biopsy. This way, the physician will be able to drive an ultra-thin robotic catheter into the patient’s lung in an almost non-traumatic procedure. Ion’s system is built to integrate seamlessly into operating rooms and bronchoscopy units.(12)
Intuitive has been one of the pioneers of robotic-assisted surgery since 1995. This technology company is currently improving minimally invasive products such as the da Vinci surgical system. They envision a future with intelligent hospitals that would improve outcomes, lower the total cost of care, and improve patient experiences.(11)One of its most ambitious projects is the Ion experience, an innovative robotic-assisted platform to enable minimally invasive biopsies that could become a crucial part of the early diagnosis of lung cancer.
It is based on PlanPoint’s software that translates a CT scan of the patient’s lung into a 3D model map to determine the nodules that need a biopsy. This way, the physician will be able to drive an ultra-thin robotic catheter into the patient’s lung in an almost non-traumatic procedure. Ion’s system is built to integrate seamlessly into operating rooms and bronchoscopy units.(12)
References